ABSTRACT
Background: Matrix metalloproteinase (MMP) enzyme gene polymorphisms MMP-2-1575G/A and MMP-9-1562C/T promoter polymorphism, their serum levels, and activity are associated with aortic valve calcification (AVC). Materials and Methods: The synergistic link between the risk of AVC and the alleles T and A of MMP-9 and MMP-2 was investigated, respectively. Ninety-two cases with AVC and 92 healthy individuals from the west of Iran were included, and MMP- 2-1575G/A and MMP-9-1562C/T promoter polymorphisms were detected using PCR-RFLP. The serum levels and activity of MMP-2 and -9 were assessed using ELISA and gelatin zymography methods, respectively. In addition, serum biochemical markers, including FBS, urea and creatinine, cholesterol, triglyceride, HDL, LDL, calcium, phosphorus, and blood pressure: systolic blood pressure and diastolic blood pressure were measured. Results: Heart valve calcification disease was associated with a comparatively higher frequency of the A allele of the MMP2-1575 variation (p = 0.002). In addition, the frequency of T allele of the MMP9-1562 variant was higher than the control group (p = 0.007). Conclusion: MMP-2 and MMP-9 serum levels and activities were observed to be considerably higher in the experimental group than in the control group (p < 0.001). Patients are more susceptible to cardiovascular disease than the control group due to elevated serum levels and activity of MMP-2 and MMP-9.
Subject(s)
Aortic Valve Stenosis , Aortic Valve , Calcinosis , Genetic Predisposition to Disease , Matrix Metalloproteinase 2 , Matrix Metalloproteinase 9 , Promoter Regions, Genetic , Humans , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/blood , Calcinosis/genetics , Calcinosis/blood , Female , Male , Iran , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase 2/blood , Aortic Valve/pathology , Promoter Regions, Genetic/genetics , Middle Aged , Aortic Valve Stenosis/genetics , Aortic Valve Stenosis/blood , Polymorphism, Single Nucleotide/genetics , Aged , Adult , Alleles , Case-Control Studies , Gene Frequency/genetics , Heart Valve Diseases/genetics , Heart Valve Diseases/blood , GenotypeABSTRACT
There is some evidence in traditional medicine for the effectiveness of Thymus vulgaris ( bÇi lÇ xiang) in the treatment of anxiety in humans. The elevated plus-maze (EPM) has broadly been used to investigate anxiolytic and anxiogenic compounds. The present study investigated the effects of extract of T. vulgaris on rat behavior in the EPM. In the present study, the data were obtained from male Wistar rats. Animals were divided into four groups: saline group and T. vulgaris groups (50 mg/kg, 100 mg/kg, and 200 mg/kg infusion for 7 days by feeding). During the test period, the total distance covered by animals, the number of open- and closed-arm entries, and the time spent in open and closed arms of the EPM were recorded. T. vulgaris increased open-arm exploration and open-arm entry in the EPM, whereas extract of this plant has no effects on the total distance covered by animals and the number of closed-arm entries. The results of the present experiment indicate that T. vulgaris may have an anxiolytic profile in rat behavior in the EPM test, which is not influenced by the locomotor activity. Further research is required to determine the mechanisms by which T. vulgaris extract exerts an anxiolytic effect in rats.
